Nicotinamide riboside (NR) supplements💊 SupplementsNEW
Nicotinamide riboside shows no benefit for early Parkinson's in yearlong JAMA trial
A JAMA-published trial of 410 people with early Parkinson's disease found no clinical benefit from nicotinamide riboside (NR), an NAD-boosting compound that is also sold as a supplement.
Low Concern
📰 News report
3h ago